Search results
Proteologix, Inc. to be Acquired by Johnson & Johnson
Benzinga· 16 hours agoProteologix's portfolio includes PX128, a bispecific antibody targeting IL-13 plus TSLP, which is ready to enter phase 1 development for moderate to severe atopic dermatitis ...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Finance· 4 hours agoFor the deal, J&J will pay $850 million in cash while being entitled to make a future milestone...
Long Dismissed, Chronic Lyme Is Finally in the Spotlight
Time via AOL· 1 day agoFalse negatives are common, especially when people are tested early in their infections, since it...
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 1 day agoResults from the phase 3 SUPERNOVA study show that the company’s investigational long-acting ...
CDC advises mpox may be making a comeback
Deseret News via Yahoo News· 59 minutes agoMichelle Budge, Deseret News A deadlier version of monkeypox — which is now being called simply mpox — is hitting the central African nation of the...
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga via Yahoo Finance· 1 day agoProteologix’s portfolio includes: PX128, a bispecific antibody targeting IL-13 plus TSLP, which is...
No link between National Childhood Vaccine Injury Act, rise in autism rates | Fact check
USA TODAY via Yahoo News· 15 minutes agoThe claim: National Childhood Vaccine Injury Act linked to increase in autism rates A May 11 Instagram post (direct link, archive link) shows a graph that depicts a decades-long rise in the ...
A rabies-infected stray cat attacked at least one person on Staten Island; NYC officials issue...
Staten Island Advance· 1 hour agoA rabies-infected stray cat recently attacked at least one person in Travis, and city officials now want residents to be on the lookout for other possibly-infected animals, a Department of Health ...
New virus variants threaten a summer Covid-19 wave, but experts say the risk remains uncertain
NewsWatch 12 Medford - Klamath Falls· 8 hours agoKP.2 — one of the so-called FLiRT variants — has overtaken JN.1 to become the dominant coronavirus...
J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
Zacks· 15 hours agoJohnson & Johnson (JNJ) inks deal to acquire Proteologix, Inc. for $850 million in cash. The transaction is expected to be closed in mid-2024.
